Table 3.
Gonadotropin dosage and duration comparisons between the ORNS group and the ORS group.
| Total | ORNS | ORS | p | |
|---|---|---|---|---|
| Total amount of FSH* (IU) | 1,960.38 ± 499.49 | 2,071.03 ± 850.57 | 1,945.03 ± 674.501 | <0.01 |
| Total days of FSH* (IU) | 12.30 ± 2.69 | 11.64 ± 3.05 | 12.39 ± 2.62 | <0.01 |
| Total amount of HMG** (IU) | 646.76 ± 734.82 | 779.36 ± 921.04 | 628.38 ± 703.21 | <0.01 |
| Total days of HMG** | 4.77 ± 3.07 | 5.02 ± 3.62 | 4.73 ± 2.98 | <0.01 |
| LH on hCG day (mIU/ml) | 1.18 ± 1.45 | 1.29 ± 1.36 | 1.16 ± 1.45 | <0.01 |
| E2 on hCG day (pg/ml) | 3,581.56 ± 2,224.21 | 3,144.43 ± 1,986.05 | 3,642.19 ± 2,248.65 | <0.01 |
| P on hCG day (ng/ml) | 0.96 ± 1.12 | 0.84 ± 0.53 | 0.98 ± 1.17 | <0.01 |
| Average E2 level of >14-mm follicles | 411.78 ± 191.96 | 363.87 ± 167.13 | 418.42 ± 194.23 | <0.01 |
| hCG value (1 day after hCG triggered) | 130.14 ± 63.52 | 134.250 ± 66.79 | 129.56 ± 63.03 | <0.01 |
*Recombinant Human Follitropin for Injection (FSH), **Human Menopausal Gonadotropin for injection (HMG).